The Human Genome Project was completed a little over twenty years ago. Now, scientists involved in the 4D Nucleome Project have created a detailed map that not only showcases the human genome in 3D, ...

Chinese researchers have developed an artificial intelligence-powered virtual drug screening platform that achieves a ...

IFLScience needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time.

Molecular biosciences Prof. Heather Pinkett has been the only Black faculty member in her department for the past 12 years. After studying biochemistry at Connecticut College, Pinkett developed a ...

In conjunction with the strategic evolution, the Company appointed Jian Irish, Ph.D., M.B.A., as Chief Executive Officer. Based on a revised capital allocation strategy, the Company extended its ...

India’s health care system is undergoing a major shift as genomics and artificial intelligence enable predictive, preventive, ...

Maze Therapeutics uses its Compass genetics platform to advance kidney and obesity drugs, with MZE829 Phase 2 data due in ...

New name reflects the Company's strategic evolution focused on later-stage preclinical assets leveraging its most advanced, signature gene-editing capabilities Pre-IND meeting held in 4Q 2025 followin ...

That’s only one problem. Your immune system also has an adaptive system of specialized immune cells and antibodies that attack and destroy invading microbes. This system remembers what those intruders ...

The U.S. next generation sequencing market size was valued at USD 2.85 billion in 2025 and is predicted to hit around USD 12.52 billion by 2035, rising at a 15.95% CAGR, a study published by Towards ...